Novo Nordisk Q3 profit drops on restructuring costs as GLP-1 and obesity drug sales rise; company narrows 2025 growth outlook.
According to the latest results from Gallup’s survey, self-reported obesity has started to fall, declining by nearly 3 points ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. How Long Does It Take for Wegovy® To Work? When considering ...